These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 23513925)

  • 1. Nanomolar inhibitors of the peptidyl prolyl cis/trans isomerase Pin1 from combinatorial peptide libraries.
    Wildemann D; Erdmann F; Alvarez BH; Stoller G; Zhou XZ; Fanghänel J; Schutkowski M; Lu KP; Fischer G
    J Med Chem; 2006 Apr; 49(7):2147-50. PubMed ID: 16570909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent advances in the study of pin1 and its inhibitors].
    Zhang CJ; Zhang ZH; Xu BL; Wang YL
    Yao Xue Xue Bao; 2008 Jan; 43(1):9-17. PubMed ID: 18357725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aryl indanyl ketones: efficient inhibitors of the human peptidyl prolyl cis/trans isomerase Pin1.
    Daum S; Erdmann F; Fischer G; Féaux de Lacroix B; Hessamian-Alinejad A; Houben S; Frank W; Braun M
    Angew Chem Int Ed Engl; 2006 Nov; 45(44):7454-8. PubMed ID: 17048295
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel spiroannulated 3-benzofuranones. Synthesis and inhibition of the human peptidyl prolyl cis/trans isomerase Pin1.
    Braun M; Hessamian-Alinejad A; de Lacroix BF; Alvarez BH; Fischer G
    Molecules; 2008 Apr; 13(4):995-1003. PubMed ID: 18463601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a real-time fluorescence monitoring system for high-throughput screening for prolyl isomerase inhibitors.
    Mori T; Itami S; Yanagi T; Tatara Y; Takamiya M; Uchida T
    J Biomol Screen; 2009 Apr; 14(4):419-24. PubMed ID: 19403925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptidyl-prolyl isomerase inhibitors.
    Wang XJ; Etzkorn FA
    Biopolymers; 2006; 84(2):125-46. PubMed ID: 16302169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mechanisms of gene regulation centered on peptidyl prolyl cis-trans isomerase].
    Horikoshi M; Himukai R; Kuzuhara T
    Tanpakushitsu Kakusan Koso; 2004 Jun; 49(8):1195-203. PubMed ID: 15209215
    [No Abstract]   [Full Text] [Related]  

  • 8. The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease.
    Lu KP; Zhou XZ
    Nat Rev Mol Cell Biol; 2007 Nov; 8(11):904-16. PubMed ID: 17878917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aryl hetaryl ketones and thioketones as efficient inhibitors of peptidyl-prolyl cis-trans isomerases.
    Hediger T; Frank W; Schumann M; Fischer G; Braun M
    Chem Biodivers; 2012 Nov; 9(11):2618-34. PubMed ID: 23161639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correlation between structure and function of peptidyl-prolyl isomerase].
    Ikura T; Kinoshita K; Ito N
    Tanpakushitsu Kakusan Koso; 2009 Feb; 54(2):167-72. PubMed ID: 19205352
    [No Abstract]   [Full Text] [Related]  

  • 11. Peptidyl-prolyl cis-trans isomerases: structure and functions.
    Pliyev BK; Gurvits BY
    Biochemistry (Mosc); 1999 Jul; 64(7):738-51. PubMed ID: 10424896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FRET-Protease-Coupled Peptidyl-Prolyl cis-trans Isomerase Assay: New Internally Quenched Fluorogenic Substrates for High-Throughput Screening.
    Caporale A; Mascanzoni F; Farina B; Sturlese M; Di Sorbo G; Fattorusso R; Ruvo M; Doti N
    J Biomol Screen; 2016 Aug; 21(7):701-12. PubMed ID: 27185744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-permeable bicyclic peptide inhibitors against intracellular proteins.
    Lian W; Jiang B; Qian Z; Pei D
    J Am Chem Soc; 2014 Jul; 136(28):9830-3. PubMed ID: 24972263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and peptidyl-prolyl isomerase inhibitory activity of quinoxalines as ligands of cyclophilin A.
    Wang F; Chen J; Liu X; Shen X; He X; Jiang H; Bai D
    Chem Pharm Bull (Tokyo); 2006 Mar; 54(3):372-6. PubMed ID: 16508195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Editorial: Phosphorylation-Dependent Peptidyl-Prolyl Cis/Trans Isomerase PIN1.
    Lim J; Lee TH; Suizu F
    Front Cell Dev Biol; 2020; 8():620418. PubMed ID: 33330517
    [No Abstract]   [Full Text] [Related]  

  • 16. Proteomics and metabolomics analyses of camptothecin-producing
    Rady AM; El-Sayed ASA; El-Baz AF; Abdel-Fattah GG; Magdeldin S; Ahmed E; Osama A; Hassanein SE; Saed H; Yassin M
    Microbiol Spectr; 2023 Dec; 11(6):e0228123. PubMed ID: 37855596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Small molecule inhibitors of phosphorylation specific peptidyl prolyl cis-trans isomerase Pin1].
    Watanabe N; Osada H
    Nihon Rinsho; 2012 Nov; 70 Suppl 8():709-17. PubMed ID: 23513925
    [No Abstract]   [Full Text] [Related]  

  • 18. Peptidyl-prolyl cis-trans isomerase Pin1 in ageing, cancer and Alzheimer disease.
    Lee TH; Pastorino L; Lu KP
    Expert Rev Mol Med; 2011 Jun; 13():e21. PubMed ID: 21682951
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.